✉news BusinessStartups first seen 1 d ago, last 22 h ago, peak #23
Belgian startup revives Galapagos CAR-T research
A Belgian biotech startup is taking over and continuing the CAR-T cell therapy research that Galapagos had previously pursued. The move keeps alive a line of immunotherapy work that the larger firm had stepped back from, and it will be watched for what it signals about the future of CAR-T development in Belgium's biotech sector.
Why now: Galapagos's retreat from CAR-T programs and the transfer of that research to a new startup is notable news for biotech investors and industry watchers.
Evidence
- Belgian startup revives Galapagos CAR-T research · BioPharma Dive
API: https://socialmediatrends-api.osmike.com/v1/trends/2383662